ResearcherMoffitt Cancer CenterActive in the last 2 years
Daniel Abate‐Daga
Matched on ORCID iD 0000-0002-2571-0215; OpenAlex author ID A5028956946; NIH RePORTER profile ID 14283645. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 11
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant
Papers 4
- Enhancing synergy of CAR T cell therapy and oncolytic virus therapy for pancreatic cancer Co-author DOI 10.1101/055988↗
- A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer. Co-author DOI 10.1089/hum.2013.209↗
- Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies. Co-author DOI 10.4161/onci.29194↗
- E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models. First author DOI 10.1038/gt.2010.114↗
Grants 1
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Steven Rosenberg · 2 shared papers, 2014 · strength 0.11
- Richard A. Morgan · 1 shared paper, 2014 · strength 0.07
- Rachel Walker · 1 shared paper, 2016 · strength 0.05
- Heiko Enderling · 1 shared paper, 2016 · strength 0.05
- Yaroslav Teper · 1 shared paper, 2014 · strength 0.04
- William R. Burns · 1 shared paper, 2014 · strength 0.04
- Richard A. Morgan · 1 shared paper, 2014 · strength 0.04
- Udo Rudloff · 1 shared paper, 2014 · strength 0.04
- Eric Tran · 1 shared paper, 2014 · strength 0.04
- Laura Garcia-Rodríguez · 1 shared paper, 2011 · strength 0.03
- Cristina Fillat Fonts · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.